作者: Bruce A. Malcolm , Xiao Tong , Hsueh-Cheng Huang
DOI:
关键词: Stereochemistry 、 Virology 、 Polymerase inhibitor 、 Hcv protease 、 Medicine
摘要: Disclosed are medicaments, pharmaceutical compositions, kits, and methods based on combinations of at least one HCV protease inhibitor polymerase but not HCV-796; for concurrent or consecutive administration in treating ameliorating more symptoms HCV, disorders associated with a subject need thereof.